OKYO Pharma Limited (OKYO)
Total Valuation
OKYO Pharma has a market cap or net worth of $49.85 million. The enterprise value is $48.02 million.
Market Cap | 49.85M |
Enterprise Value | 48.02M |
Important Dates
The next estimated earnings date is Tuesday, April 9, 2024, before market open.
Earnings Date | Apr 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
OKYO Pharma has 33.24 million shares outstanding. The number of shares has increased by 29.71% in one year.
Shares Outstanding | 33.24M |
Shares Change (YoY) | +29.71% |
Shares Change (QoQ) | +32.82% |
Owned by Insiders (%) | 25.72% |
Owned by Institutions (%) | 2.53% |
Float | 13.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72
Current Ratio | 0.72 |
Quick Ratio | 0.64 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -136.39 |
Financial Efficiency
Return on equity (ROE) is -2,968.50% and return on invested capital (ROIC) is -8,146.58%.
Return on Equity (ROE) | -2,968.50% |
Return on Assets (ROA) | -279.30% |
Return on Capital (ROIC) | -8,146.58% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.66M |
Employee Count | 8 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -12,202 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.50% in the last 52 weeks. The beta is -3.17, so OKYO Pharma's price volatility has been lower than the market average.
Beta (1Y) | -3.17 |
52-Week Price Change | +14.50% |
50-Day Moving Average | 1.49 |
200-Day Moving Average | 1.63 |
Relative Strength Index (RSI) | 50.19 |
Average Volume (30 Days) | 192,644 |
Short Selling Information
The latest short interest is 50,789, so 0.15% of the outstanding shares have been sold short.
Short Interest | 50,789 |
Short Previous Month | 64,634 |
Short % of Shares Out | 0.15% |
Short % of Float | 0.37% |
Short Ratio (days to cover) | 1.48 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -13.19M |
Pretax Income | -13.28M |
Net Income | -13.27M |
EBITDA | -13.18M |
EBIT | -13.19M |
Earnings Per Share (EPS) | -$0.61 |
Balance Sheet
The company has $4.05 million in cash and $2.22 million in debt, giving a net cash position of $1.83 million or $0.06 per share.
Cash & Cash Equivalents | 4.05M |
Total Debt | 2.22M |
Net Cash | 1.83M |
Net Cash Per Share | $0.06 |
Equity / Book Value | -2.05M |
Book Value Per Share | -0.06 |
Working Capital | -2.06M |
Cash Flow
In the last 12 months, operating cash flow was -$7.70 million and capital expenditures -$5,916, giving a free cash flow of -$7.70 million.
Operating Cash Flow | -7.70M |
Capital Expenditures | -5,916 |
Free Cash Flow | -7.70M |
FCF Per Share | -$0.27 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
OKYO Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -29.71% |
Shareholder Yield | -29.71% |
Earnings Yield | -26.62% |
FCF Yield | -15.45% |
Analyst Forecast
The average price target for OKYO Pharma is $7.00, which is 379.45% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $7.00 |
Price Target Difference | 379.45% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |